Insiders · Profile

Ali-Jackson Kamil

Director at RIGEL PHARMACEUTICALS · Director at PDS Biotechnology · Chief Legal Officer at Aclaris Therapeutics. Filing since 26 Aug 2016. CIK 0001654337

Company
Date
Role
Action
Shares
Amount
Of holding
22 Jun 2026
Director
Sold on a plan
2,500
$87.50K
19.8%
26 May 2026
Director
Sold on a plan
2,500
$72.93K
16.5%
15 Jun 2021
Director
Bought
11,764
$99.99K
opened
3 Jun 2021
Chief Legal Officer
Sold, plan not stated
9,492
$208.42K
7.2%
2 Jun 2021
Chief Legal Officer
Sold, plan not stated
30,119
$651.66K
18.6%
1 Jun 2021
Chief Legal Officer
Sold, plan not stated
15,000
$345.30K
8.5%
7 May 2021
Chief Legal Officer
Sold, plan not stated
5,416
$127.39K
3.6%
6 May 2021
Chief Legal Officer
Sold, plan not stated
15,000
$351.45K
9.5%
5 May 2021
Chief Legal Officer
Sold, plan not stated
15,000
$359.71K
9.5%
4 May 2021
Chief Legal Officer
Sold, plan not stated
15,000
$355.19K
9.5%
3 May 2021
Chief Legal Officer
Sold, plan not stated
15,000
$368.82K
9.5%
12 Jun 2018
Chief Legal Officer
Sold, plan not stated
4,900
$98.00K
5.9%
11 Jun 2018
Chief Legal Officer
Sold, plan not stated
100
$2.00K
0.1%
18 May 2018
Chief Legal Officer
Sold, plan not stated
10,000
$200.00K
10.8%
26 Oct 2016
Chief Legal Officer
Sold, plan not stated
3,912
$85.40K
4.9%
28 Sep 2016
Chief Legal Officer
Sold, plan not stated
1,841
$45.40K
2.4%
26 Aug 2016
Chief Legal Officer
Sold, plan not stated
3,738
$76.07K
15.6%
17 decisions on file.